Clinical Trial Update: Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1 and Phase 2 clinical trial is evaluating allogeneic adipose tissue-derived mesenchymal stem cells to induce remission in ulcerative colitis; the curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Allogeneic adipose tissue-derived mesenchymal stem cells

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: UNKNOWN